Data for samtidig brug af parenteral midazolam med andre proteasehæmmere peger på en mulig 3- 4- dobbelt forøgelse af midazolams plasmaniveau.
Data from concomitant use of parenteral midazolam with other protease inhibitors suggest a possible 3-4 fold increase in midazolam plasma levels.